Scientific Name(s): Pueraria mirifica Airy Shaw et. Suvatabhandu.
Common Name(s): Kwao Keur, Kwao Krua, Kwao Kruea, White Kwao Krua
Most commercial products containing pueraria are available as rejuvenating, antiaging, or skin-lightening creams or gels, as beauty soaps, or as capsules or tablets for increasing appetite, enlarging breasts, modulating hair growth or regrowth, and other rejuvenating purposes. However, there is no literature to support these uses. The medical literature documents the plant's use primarily for menopause, but also for cancer and osteoporosis.
Commercial products are available in topical (creams, gels, and soaps) or oral (capsules or tablets) dosage forms. Some clinical studies used 200 to 400 mg (extracted from the root or tuber) by mouth per day. Commercial manufacturers suggest 250 mg (root or tuber) by mouth every morning and evening. For breast enlargement, manufacturers suggest a twice-daily topical application to the breast area for 3 to 5 minutes until fully absorbed.
Avoid use if hypersensitive to any of the components of product. Because of its phytoestrogen-like effects, use pueraria with caution if diagnosed with an estrogen-dependent neoplasia, pulmonary embolism, liver dysfunction or disease, or anemia.
Avoid use during pregnancy and lactation because of the lack of clinical data and the plant's phytoestrogen activity.
None well documented.
Because of pueraria's estrogen-like effect, use with caution in patients with asthma, diabetes mellitus, epilepsy, migraine, or systemic lupus erythematosus. Use with caution in patients with abnormal triglycerides or hypercalcemia.
The plant species P. mirifica (pueraria) belongs to the Fabaceae, or bean, subfamily, and its tuberous roots contain several phytoestrogens.Manonai 2007 P. mirifica is a woody vine commonly found in forests throughout ThailandMalaivijitnond 2006 with 28 cultivars presently documented. The tuberous root varies in size depending on soil condition, but may weigh as much as 100 kg. The plant's palmate-type leaves are simple or ovate and contain 3 leaflets in 1 petiole. The blue-to-purple flowers are composed of 5 petals and bloom from February to March.
The plant species is rich in phytoestrogens, and postmenopausal women in Thailand have consumed it for more than 100 years citing its beneficial estrogen effects.Manonai 2008 In traditional Thai medicine, it is common to use P. mirifica as a skin moisturizer, to improve regrowth of hair, to improve body flexibility and sexual performance, and to firm and enlarge the breasts.Malaivijitnond 2006 Commercial products containing pueraria are continually introduced into the world marketSookvanichsilp 2008 and have become popular in Thailand, Korea, and Japan.Malaivijitnond 2006 Most commercial products are available as topical rejuvenating, antiaging, or skin-lightening creams or gels, as beauty soaps, or as capsules or tablets for increasing appetite, enlarging breasts, modulating hair growth or regrowth, and other rejuvenating purposes.Sookvanichsilp 2008, Malaivijitnond 2006, Chansakaow 2000, Liang 2000, Roufs 2007, Yagi 2007, Tehara 2006, Liu 2005, Konoike 2006, Ishiwatari 2003 Since 1999, domestic and global demand for the raw materials from P. mirifica roots or tubers has increased, resulting in intense harvesting of the plant from the forests of Thailand.Cherdshewasart 2007
Isoflavones, coumestans, and lignans are the 3 main classes of phytoestrogens. The tuberous roots of P. mirifica primarily contain the active component miroestrol and its derivative, deoxymiroestrol.Chansakaow 2000 The tuberous roots of P. mirifica also contain daidzin, daidzein, genistin, genistein, puerarinIngham 1986 mirificoumestan, kwakhurinIngham 1986, Tahara 1987 coumestrolIngham 1988 mirificin, and 2 steroids, estrone and estriol.Sookvanichsilp 2008, Ingham 1986, Ingham 1989, Chansakaow 2000 The manufacture and synthesis of miroestrol is documented.Corey 1993, Ishikawa 2006 Deoxymiroestrol was isolated and identified as the most active phytoestrogen of the plant.Cherdshewasart 2004, Sookvanichsilp 2008, Ishikawa 2001
Thin-layer chromatography analysis has documented varying amounts of phytoestrogens collected from P. mirifica in different locations in Thailand.Malaivijitnond 2006, Cherdshewasart 2007 One of the challenges of large-scale manufacturing of P. mirifica for drugs and cosmetics is resolving these variations in lots.
Uses and Pharmacology
Some of the isoflavonoids in P. mirifica had antioxidant activity similar to that of alpha tocopherol or vitamin E.Cherdshewasart 2008P. mirifica decreased neuronal cell death in a time- and dose-dependent manner against neurotoxic agents in an Alzheimer disease model in vitro.Sucontphunt 2007, Sawatsri 2004 Mechanism of action may be associated with an effect on synaptic density by inducing synaptophysin expression via estrogen receptor.Chindewa 2008
Spinasterol, an active cytotoxic component of P. mirifica, was active against certain gynecological cancer cell lines and activates estrogen receptors ER-alpha and ER-beta. The ethanol extract had antiproliferative effects on breast cancer cell lines MCF-7, ZR-75-1, MDA-MB-231, SK-BR-3, and Hs578T. Another component, known as PE-D, affected the growth in a dose-dependent and time-dependent manner on some breast cancer cell lines (MCF-7, MDAMB-231), and on the growth of ovarian (2774) and cervical cancer cells (HeLa).Baek 2003, Jeon 2005 The estrogenic effect of some components in P. mirifica has been compared with estradiol, a major estrogen in humans.Jeon 2005, Cherdshewasart 2008 The rank order of phytoestrogen potency is: deoxymiroestrol; miroestrol; 8-prenylnaringenin; coumestrol; genistein/equol; daidzein; resveratrol.Matsumura 2005P. mirifica also had an estrogenic effect on a human HepG2 hepatoma cell line that contained an estrogen receptor and a luciferase reporter gene; this evidence indicates that metabolic activation of P. mirifica promotes estrogenic activity.Lee 2002 Another study also documents that estrogenic activity may result from metabolic activation of liver enzymes.Cherdshewasart 2008
The proposed mechanism of action involves strong competitive binding of the plant's phytoestrogens to ER-alpha and/or synthesis suppressor of ER-alpha.Cherdshewasart 2007
Pretreatment of rats with P. mirifica (1,000 mg/kg body weight per day tuberous root powder) resulted in decreased virulence of rat mammary tumor development from 7,12-dimethylbenz(a)anthracene (7,12-DMBA). Histopathological analysis of the mammary tumor tissues revealed lower ER-alpha, ER-beta, and ER-alpha/ER-beta profile.Cherdshewasart 2007
Cognitive improvements were reported in ovariectomized rats administered P. mirifica extract and pure puerarin, with the researchers suggesting potential applications in cognitive decline due to ageing.Anukulthanakorn 2016
The active ingredients from the root of P. mirifica had lethal properties during various growth cycles against the yellow fever mosquito (Aedes aegypti) and other mosquito species with disease-spreading abilities.Lapcharoen 2005
In rabbits, P. mirifica improved endothelial function through a nitric oxide pathway, decreased contractile responses to norepinephrine, and increased responses to estradiol. The plant caused no changes in lipid profile or liver enzymes.Wattanapitayakul 2005 In male and female gonadectomized rats, P. mirifica had estrogen-like activity and affected accessory sex organs. It increased luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in both sexes.Malaivijitnond 2004 The mechanism of action involved direct stimulation of the accessory sex organs and suppression of the hypothalamic-pituitary-gonadal axis. Overall activity was more potent in female rats than in male rats. Studies in mice found that P. mirifica does not affect male fertility or the hypothalamus-pituitary-testis axis.Jaroenporn 2006 The testis, epididymis, and seminal vesicle all had normal histopathology in P. mirifica -treated male mice.
P. mirifica may greatly alter the length of menstrual cycles and suppress ovulation by reducing serum levels of gonadotropins. The length of the menstrual cycle increased in monkeys treated with P. mirifica 10 and 100 mg/day of root extract and disappeared completely in monkeys treated with root extract 1,000 mg/day. Serum FSH, LH, estradiol, progesterone, and immunoreactive-irinhibin were lower in a dose-dependent manner during treatment. During the posttreatment period, only monkeys treated with P. mirifica 10 and 100 mg/day of extract recovered from the changes in menstrual cycle length and hormone levels.Trisomboon 2005 Other studies document similar activity for the P. mirifica 1,000 mg/day dose of Trisomboon 2004 root extract and the direct correlation in dose with gonadotrophin levels.Trisomboon 2006
The plant had a dose-dependent estrogenic effect on rat vaginal cornification.Cherdshewasart 2007P. mirifica phytoestrogens at a dose of root extract 1,000 mg/day decreased serum parathyroid hormone and calcium levels in aged menopausal monkeys and, thus, may be beneficial in treating bone loss caused by estrogen deficiency.Trisomboon 2004P. mirifica had an estrogenic action in aged menopausal monkeys by changing the sexual skin area around the perineum to the base of the tail to a reddish pigmentation.Trisomboon 2006 FSH may be a candidate marker for the study of P. mirifica's estrogenic effects in female monkeys if changes in urinary hormones are used as an indicator.Trisomboon2007, Trisomboon 2007
In a 24-week randomized, double-blind, placebo-controlled trial of 51 postmenopausal women, oral P. mirifica exhibited estrogenicity on vaginal tissue, alleviated vaginal dryness symptoms and dyspareunia, improved signs of vaginal atrophy, and restored atrophic vaginal epithelium.Manonai 2007 In another clinical trial of 51 postmenopausal women 46 to 60 years of age, P. mirifica tuberous root had an estrogen-like effect on bone turnover rate at a dose of 20, 30, and 50 mg/day for a 24-week period.Manonai 2008 Phase 1 to 3 trials in Thailand compared the estrogenic effect of P. mirifica to conjugated equine estrogen in relieving climacteric symptoms in perimenopausal women.Lamlertkittikul 2004, Chandeying 2007
A small (n=52) clinical study evaluated oral P. mirifica at 25 and 50 mg over 6 months in relieving menopausal symptoms, and reported efficacy for both doses. The researchers suggest 1 mg of P. mirifica is equivalent to 0.52 to 0.75 mcg of ethinyl estradiol.Virojchaiwong 2011
Similar to findings in monkeys,Jaroenporn 2014 a randomized clinical study (n=82) reported P. mirifica gel to be effective in improving signs of vaginal atrophy and restoring vaginal epithelium at 6 and 12 weeks, but to a lesser extent than conjugated estrogen cream.Suwanvesh 2017
In small clinical trials, the administration of P. mirifica crude extract improved hot flushes, frustration, sleep disorder, skin dryness, high blood cholesterol, amenorrhea, and other menopause-related symptoms in women. There was no change in blood cells or liver and renal function.Hosoyama 2007, Muangman 2001
In sex-hormone–deficient male rats, treatment with P. mirifica root powder completely inhibited bone loss in long bones and axial bones. At higher doses, it increased bone density without affecting accessory sex organs.Urasopon 2007 In a similar study, P. mirifica completely inhibited bone loss in long bones and axial bones in estrogen-deficient female rats.Urasopon 2008 However, the highest dose of P. mirifica root powder (1,000 mg/kg body weight per day) caused an undesired adverse reaction of increased uterine weight.
In postmenopausal osteoporotic monkeys oral administration of P. mirifica improved both bone quality and quantity.Kittivanichkul 2016
Commercial products are available as topical creams, gels, and soaps, or in oral capsule and tablet dosage forms.Sookvanichsilp 2008, Malaivijitnond 2006, Chansakaow 2000, Liang 2000, Roufs 2007, Yagi 2007, Tehara 2006, Liu 2005, Konoike 2006, Ishiwatari 2003 Some clinical studies used 200 to 400 mg extract from root or tuber orally per day. Commercial manufacturers suggest a dosage of 250 mg of active ingredients from the root orally every morning and evening. For topical products, manufacturers suggest a twice-daily topical application to the breast area for 3 to 5 minutes until fully absorbed.
A small (n= 52) clinical study evaluated oral P. mirifica at 25 and 50 mg over 6 months in relieving menopausal symptoms, and reported efficacy for both doses. The researchers suggest 1 mg of P. mirifica is equivalent to 0.52 to 0.75 mcg of ethinyl estradiol.Virojchaiwong 2011
Pregnancy / Lactation
Avoid use during pregnancy and lactation because of the lack of clinical data and the plant's phytoestrogen activity.
Phytoestrogens have estrogen-like effects. Theoretically, drug interactions may occur with the following:
Corticosteroids (eg, prednisone)
May increase pharmacologic and toxicologic effects.
Hydantoins (eg, phenytoin)
May affect concentration of these medications.
Thyroid hormones (eg, levothyroxine)
May decrease serum free thyroxine concentrations.
Increased triglyceride levels may occur.Manonai 2008
Because of the estrogen-like effect of P. mirifica, use with caution in patients with asthma, diabetes mellitus, epilepsy, migraine, or systemic lupus erythematosus. Also use with caution in patients with abnormal triglyceridesManonai 2008 or hypercalcemia.Manonai 2008, Urasopon 2007, Urasopon 2008
High doses of P. mirifica caused general and genotoxicity in animals.Saenphet 2005 Rats treated with aqueous and ethanolic root extracts of P. mirifica had significantly lower body weight gain and lower packed red cell volume; the plant also had mutagenic activity.Sanchanta 2005 A root extract dosage of 100 mg/kg had adverse effects on mating efficiency and reproduction in female mice.Jaroenporn 2007 No estrogen hormone activities were found in egg and chicken meat tissue or rats.Tubcharoen 2003, Tubcharoen 2003 The median lethal dose for oral consumption of P. mirifica root powder in mice was 2,000 mg/kg body weight per day.Cherdshewasart 2003
Anukulthanakorn K, Parhar IS, Jaroenporn S, et al. Neurotherapeutic effects of Pueraria mirifica
extract in early-and late-stage cognitive impaired rats. Phytother Res
Baek DH, E SJ, Jun GC, et al. Composition comprising alcohol extract of pueraria sp. Roots [in Korean]. Repub. Korean Kongkae Taeho Kongbo
. US patent application KR 2003-089396. 2003.
Chandeying V, Sangthawan M. Efficacy comparison of Pueraria mirifica
(PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study. J Med Assoc Thai
Chansakaow S, Ishikawa T, Seki H, et al. Rejuvenating principles of Pueraria mirifica
. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu
Chansakaow S, Ishikawa T, Seki H, Sekine (née Yoshizawa) K, Okada M, Chaichantipyuth C. Identification of deoxymiroestrol as the actual rejuvenating principle of "Kwao Keur", Pueraria mirifica
. The known miroestrol may be an artifact. J Nat Prod
Chansakaow S, Ishikawa T, Sekine K, Okada M, Higuchi Y, Kudo M, Chaichantipyuth C. Isoflavonoids from Pueraria mirifica
and their estrogenic activity. Planta Med
Cherdshewasart W. Toxicity tests of phytoestrogen-rich herb, Pueraria mirifica
. J Sci Res Chulalongkorn U
Cherdshewasart W, Cheewasopit W, Picha P. The differential anti-proliferation effect of white (Pueraria mirifica
), red (Butea superba
), and black (Mucuna collettii
) Kwao Krua plants on the growth of MCF-7 cells. J Ethnopharmacol
Cherdshewasart W, Kitsamai Y, Malaivijitnond S. Evaluation of the estrogenic activity of the wild Pueraria mirifica
by vaginal cornification assay. J Reprod Dev
Cherdshewasart W, Panriansaen R, Picha P. Pretreatment with phytoestrogen-rich plant decreases breast tumor incidence and exhibits lower profile of mammary ERalpha and ERbeta. Maturitas
Cherdshewasart W, Sriwatcharakul S. Major isoflavonoid contents of the 1-year-cultivated phytoestrogen-rich herb, Pueraria mirifica
. Biosci Biotechnol Biochem
Cherdshewasart W, Sriwatcharakul S. Metabolic activation promotes estrogenic activity of the phytoestrogen-rich plant. Maturitas
Cherdshewasart W, Subtang S, Dahlan W. Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica
in comparison with Pueraria lobata
. J Pharm Biomed Anal
Cherdshewasart W, Sutjit W. Correlation of antioxidant activity and major isoflavonoid contents of the phytoestrogen-rich Pueraria mirifica
and Pueraria lobata
Cherdshewasart W, Traisup V, Picha P. Determination of the estrogenic activity of wild phytoestrogen-rich Pueraria mirifica
by MCF-7 proliferation assay. J Reprod Dev
Chindewa R, Lapanantasin S, Sanvarinda Y, Chongthammakun S. Pueraria mirifica
, phytoestrogen-induced change in synaptophysin expression via estrogen receptor in rat hippocampal neuron. J Med Assoc Thai
Corey EJ, Wu LI. Enantioselective total synthesis of miroestrol. J Am Chem Soc
Hosoyama H, Kuwahata R, Suga M. Menopausal disorder or skin aging preventing agents and food containing Pueraria mirifica
and soybean isoflavones. Jpn, Kokai Tokkyo Koho
. 2007: 7 pp.17957910
Ingham JL, Markham KR, Dziedzic SZ, Pope GS. Puerarin 6'-O-beta-apiofuranoside, a C-glycosylisoflavone O-glycoside from Pueraria mirifica
Ingham JL, Tahara S, Dziedzic SZ. A chemical investigation of Pueraria mirifica
roots. J Biosci
Ingham JL, Tahara S, Dziedzic SZ. Coumestans from the roots of Pueraria mirifica
. J Biosci
Ingham JL, Tahara S, Dziedzic SZ. Minor isoflavones from the roots of Pueraria mirifica
. J Biosci
Ishikawa T, Higuchi Y. Manufacture of miroestrol from Pueraria mirifica
[in Japanese]. Jpn, Kokai Tokkyo Koho
. US patent application JP 2006-290822. 2006.
Ishikawa T, Sekine K. Deoxymiroestrol as estrogen agonist and their therapeutic use [in Japanese]. Jpn, Kokai Tokkyo Koho
. US patent application JP 2001-122871. 2001.
Ishiwatari S. Irritation-decreasing compositions containing plant extracts for cosmetics and pharmaceuticals [in Japanese]. Jpn. Kokai Tokkyo Koho
. US patent application JP 2003-155246. 2003.
Jaroenporn S, Malaivijitnond S, Wattanasirmkit K, Trisomboon H, Watanabe G, Taya K, Cherdshewasart W. Effects of Pueraria mirifica
, an herb containing phytoestrogens, on reproductive organs and fertility of adult male mice. Endocrine
Jaroenporn S, Malaivijitnond S, Wattanasirmkit K, Watanabe G, Taya K, Cherdshewasart W. Assessment of fertility and reproductive toxicity in adult female mice after long-term exposure to Pueraria mirifica
herb. J Reprod Dev
Jaroenporn S, Urasopon N, Watanabe G, Malaivijitnond S. Improvements of vaginal atrophy without systemic side effects after topical application of Pueraria mirifica
, a phytoestrogen-rich herb, in postmenopausal cynomolgus macaques. J Reprod Dev
Jeon GC, Park MS, Yoon DY, Shin CH, Sin HS, Um SJ. Antitumor activity of spinasterol isolated from Pueraria roots. Exp Mol Med
Kittivanichkul D, Charoenphandhu N, Khemawoot P, Malaivijitnond S. Pueraria mirifica
alleviates cortical bone loss in naturally menopausal monkeys. J Endocrinol
Konoike S, Yamashita Y. Antiaging cosmetics containing acylated oligopeptides and Pueraria plants [in Japanese]. Jpn, Kokai Tokkyo Koho
. US patent application JP 2006-176431. 2006.
Lamlertkittikul S, Chandeying V. Efficacy and safety of Pueraria mirifica
(Kwao Kruea Khao) for the treatment of vasomotor symptoms in perimenopausal women: Phase II Study. J Med Assoc Thai
Lapcharoen P, Apiwathnasorn C, Komalamisra N, Dekumyoy P, Palakul K, Rongsriyam Y. Three indigenous Thai medicinal plants for control of Aedes aegypti
and Culex quinquefasciatus
. Southeast Asian J Trop Med Public Health
. 2005;36(suppl 4):167-175.16438204
Lee YS, Park JS, Cho SD, Son JK, Cherdshewasart W, Kang KS. Requirement of metabolic activation for estrogenic activity of Pueraria mirifica
. J Vet Sci
Liang G. Preparation of beauty soap from Pueraria mirifica
[in Chinese]. Faming Zhuanli Shenqing Gongkai Shuomingshu
. US patent application CN 2000-109346. November 1, 2000.
Liu X, Lin W. A Chinese medicinal cosmetic with wrinkle dispelling and skin caring effects and its preparation [in Chinese]. Faming Zhuanli Shenqing Gongkai Shuomingshu
. US patent application CN 1579366. 2005.
Malaivijitnond S, Chansri K, Kijkuokul P, Urasopon N, Cherdshewasart W. Using vaginal cytology to assess the estrogenic activity of phytoestrogen-rich herb. J Ethnopharmacol
Malaivijitnond S, Kiatthaipipat P, Cherdshewasart W, Watanabe G, Taya K. Different effects of Pueraria mirifica
, a herb containing phytoestrogens, on LH and FSH secretion in gonadectomized female and male rats. J Pharmacol Sci
Manonai J, Chittacharoen A, Theppisai U, Theppisai H. Effect of Pueraria mirifica
on vaginal health. Menopause
Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H, Theppisai U. Effects and safety of Pueraria mirifica
on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Menopause
Matsumura A, Ghosh A, Pope GS, Darbre PD. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J Steroid Biochem Mol Biol
Muangman V, Cherdshewasart W. Clinical trial of the phytoestrogen rich herb, Pueraria mirifica
as a crude drug in the treatment of symptoms in menopausal women. Siriraj Hosp Gaz
Roufs JB, Duvel LA, Fast DJ, Glynn KM. Methods and compositions comprising plant extracts for modulating hair growth or regrowth. US patent application 2007-036742. 2007.
Saenphet K, Kantaoop P, Saenphet S, Aritajat S. Mutagenicity of Pueraria mirifica
Airy Shaw & Suvatabandhu and antimutagenicity of Thunbergia laurifolia
Linn. Southeast Asian J Trop Med Public Health
. 2005;36(suppl 4):238-241.16438216
Sanchanta P, Saenphet K, Saenphet S, Aritajat S, Wongsawad C. Toxicological study of aqueous and ethanolic extracts from Pueraria mirifica
Airy Shaw and Suvatabandhu on male rats. In: Brovelli E, Chansakaow S, Farias D, et al, eds. III WOCMAP Congress on Medicinal and Aromatic Plants - Volume 5: Quality, Efficacy, Safety, Processing and Trade in Medicinal and Aromatic Plants
. Leuven, Belgium: International Society for Horticultural Science; 2005.
Sawatsri S, Yamkunthong W, Sidell N. P3-206 Pseuraria mirifica
initiative promotes the cellular mechanism of neuronal survival in neuron human nueuroblastoma cells. Neurobiol Aging
Sookvanichsilp N, Soonthornchareonnon N, Boonleang C. Estrogenic activity of the dichloromethane extract from Pueraria mirifica
Sucontphunt A, Dimitrijevich SD, Nimmannit U, De-Eknamkul W, Gracy RW. Antioxidant and neuroprotective activity of Pueraria mirifica
extracts against glutamate toxicity in neuronal cells. Paper presented at: American Chemical Society 234th National Meeting; August 19-23, 2007: Boston, MA.
Suwanvesh N, Manonai J, Sophonsritsuk A, Cherdshewasart W. Comparison of Pueraria mirifica
gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Menopause
Tahara S, Ingham JL, Dziedzic SZ. Structure elucidation of kwakhurin, a new prenylated isoflavone from Pueraria mirifica
roots. J Biosci
Tehara T. Antiaging cosmetics containing natural products [in Japanese]. Jpn, Kokai Tokkyo Koho
. US patent application JP 2006-241033. 2006.
Trisomboon H, Malaivijitnond S, Cherdshewasart W, Watanabe G, Taya K. Assessment of urinary gonadotropin and steroid hormone profiles of female cynomolgus monkeys after treatment with Pueraria mirifica
. J Reprod Dev
Trisomboon H, Malaivijitnond S, Cherdshewasart W, Watanabe G, Taya K. Effect of Pueraria mirifica
on the sexual skin coloration of aged menopausal cynomolgus monkeys. J Reprod Dev
Trisomboon H, Malaivijitnond S, Cherdshewasart W, Watanabe G, Taya K. The influence of Pueraria mirifica
herb containing phytoestrogens on the urinary gonadotropin and estradiol levels in aged menopausal monkeys. Animal Sci J
Trisomboon H, Malaivijitnond S, Suzuki J, Hamada Y, Watanabe G, Taya K. Long-term treatment effects of Pueraria mirifica
phytoestrogens on parathyroid hormone and calcium levels in aged menopausal cynomolgus monkeys. J Reprod Dev
Trisomboon H, Malaivijitnond S, Watanabe G, Cherdshewasart W, Taya K. The estrogenic effect of Pueraria mirifica
on gonadotrophin levels in aged monkeys. Endocrine
Trisomboon H, Malaivijitnond S, Watanabe G, Taya K. Estrogenic effects of Pueraria mirifica
on the menstrual cycle and hormone-related ovarian functions in cyclic female cynomolgus monkeys. J Pharmacol Sci
Trisomboon H, Malaivijitnond S, Watanabe G, Taya K. Ovulation block by Pueraria mirifica
: a study of its endocrinological effect in female monkeys. Endocrine
Tubcharoen S, Chiwatansin W, Saardrak K, Mata N. The optimum level of Pueraria mirifica
in stewer rabbit rations. In Proceedings of the 41st Kasetsart University Annual Conference; February 3-7, 2003; Kanchanaburi, Thailand: 331-337.
Tubcharoen S, Tungtakulsub P, Saardrak K, Sanguanphan S. Effect of Pueraria mirifica
as layer diet on peak-egg production of laying hens. In Proceedings of the 41st Kasetsart University Annual Conference; February 3-7, 2003; Kanchanaburi, Thailand: 315-322.
Urasopon N, Hamada Y, Asaoka K, Cherdshewasart W, Malaivijitnond S. Pueraria mirifica
, a phytoestrogen-rich herb, prevents bone loss in orchidectomized rats. Maturitas
Urasopon N, Hamada Y, Cherdshewasart W, Malaivijitnond S. Preventive effects of Pueraria mirifica
on bone loss in ovariectomized rats. Maturitas
Virojchaiwong P, Suvithayasiri V, Itharat A. Comparison of Pueraria mirifica
25 and 50 mg for menopausal symptoms. Arch Gynecol Obstet
Wattanapitayakul SK, Chularojmontri L, Srichirat S. Effects of Pueraria mirifica
on vascular function of ovariectomized rabbits. J Med Assoc Thai
. 2005;88(suppl 1):S21-S29.16862667
Yagi N, Shindo M, Aso Masahiro. Skin-lightening and antiaging cosmetics containing Pueraria mirifica
rhizome extracts. Jpn Kokai Tokkyo Koho
[in Japanese]. US patent application JP 2007-126395. 2007.
This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.
This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.
Copyright © 2018 Wolters Kluwer Health
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.